Analysis of sleep quality, disease uncertainty, and psychological tolerance in patients undergoing chemotherapy for digestive tract malignancies

Table 2 Comparison of data between the sleep disorder group and the normal sleep group

Variables	Group	Sleep disorders group (n = 78)	Normal sleep group (n = 53)	χ2/t	P value
Sex	Male	62 (79.49)	38 (71.70)	1.060	0.303
	Female	16 (20.51)	15 (28.30)
Age	-	68.74 ± 6.95	64.82 ± 6.56	3.241	< 0.001
Educational level	Junior high school and below	36 (46.15)	25 (47.17)	0.013	0.909
	High school and above	42 (53.85)	28 (52.83)
Residence	Town	48 (61.54)	33 (62.26)	0.007	0.933
	Rural	30 (38.46)	20 (37.74)
Chemotherapy regimen	FOLFOXIRI	45 (57.69)	32 (60.38)	0.094	0.759
	FOLFOX	33 (42.31)	21 (39.62)
Chemotherapy frequency	≤ 6	68 (87.18)	52 (98.11)	4.905	0.027
	> 6	10 (12.82)	1 (1.89)
Pain level	Mild	68 (85.90)	52 (98.11)	-	0.0361
	Moderate	9 (12.82)	1 (1.89)
	Severe	1 (1.28)	0 (0)
SAS score	-	57.43 ± 5.86	46.62 ± 4.58	11.286	< 0.001
SDS score	-	58.17 ± 5.69	44.23 ± 4.75	14.689	< 0.001
Ward noise	Yes	30 (38.46)	10 (18.87)	5.712	0.017
	No	48 (61.54)	43 (81.13)

¹Indicates using Fisher's exact probability method. SAS: Self-rating anxiety scale; SDS: Self-rating depression scale.